[1]Locationinpatent:schemeortableZhao,Chunlin;Tovar,Christian;Yin,Xuefeng;Xu,Qui;Todorov,IvanT.;Vassilev,LyubomirT.;Chen,Li[BioorganicandMedicinalChemistryLetters,2009,vol.19,#2,p.319-323]
[1]CurrentPatentAssignee:BAYERAG-US2015/239847,2015,A1
49711-14-0 | (E)-3-(naphthalen-2-yl)acrylic acid | AA00DJ60 | MFCD00209666
54090-42-5 | 4-Chloro-2-(trifluoromethyl)benzenesulphonyl chloride | AA00DJI5 | MFCD04638751
502612-43-3 | 5,6,7,8-Tetrahydro-5-isoquinolinamine hydrochloride | AA00DJPW | MFCD08235027
5461-89-2 | 4-Chloro-6,7-dihydro-5h-cyclopenta[d]pyrimidin-2-amine | AA00DK0I | MFCD18916997
527681-33-0 | Chroman-7-carboxylic acid | AA00DKC3 | MFCD14706361
444581-50-4 | 1-Bromo-2-(isobutylsulfonyl)benzene | AA00DKHJ | MFCD21332954
55104-32-0 | 6-Hydroxyphthalide | AA00DKMR | MFCD08693507
473545-40-3 | (R)-tert-Butyl (1,3-dihydroxy-3-methylbutan-2-yl)carbamate | AA00DKXF | MFCD22690369
444891-21-8 | tert-Butyl 4-(cyano(phenyl)methyl)piperazine-1-carboxylate | AA00DL7Y | MFCD09910427
450412-27-8 | Ethyl 5-bromo-2-iodobenzoate | AA00DLJ0 | MFCD12025359
114971-53-8
926197-06-0
159976-73-5
690-12-0
893786-57-7
942010-36-8